Log in
Enquire now

List of Quintessence Biosciences patents

List of Quintessence Biosciences patents
List of ManageIQ patents
List of Carna Biosciences patents
List of Lexicon Pharmaceuticals, Inc. patents
List of founders from Amsterdam
Films directed by Otto Brower
Patents where
Current Assignee
Name
is
Quintessence BiosciencesQuintessence Biosciences
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 8697065 Non-natural ribonuclease conjugates as cytotoxic agents

Patent 8697065 was granted and assigned to Quintessence Biosciences on April, 2014 by the United States Patent and Trademark Office.

Quintessence Biosciences
Quintessence Biosciences
Quintessence Biosciences
Quintessence Biosciences
United States Patent and Trademark Office
United States Patent and Trademark Office
8697065
April 15, 2014
‌
US Patent 8029782 Therapeutic ribonucleases

Patent 8029782 was granted and assigned to Quintessence Biosciences on October, 2011 by the United States Patent and Trademark Office.

Quintessence Biosciences
Quintessence Biosciences
United States Patent and Trademark Office
United States Patent and Trademark Office
8029782
October 4, 2011
‌
US Patent 9006407 Therapeutic ribonucleases

Patent 9006407 was granted and assigned to Quintessence Biosciences on April, 2015 by the United States Patent and Trademark Office.

Quintessence Biosciences
Quintessence Biosciences
Quintessence Biosciences
Quintessence Biosciences
United States Patent and Trademark Office
United States Patent and Trademark Office
9006407
April 14, 2015
‌
US Patent 8697062 Compositions and methods for ribonuclease-based therapeutics

Patent 8697062 was granted and assigned to Quintessence Biosciences on April, 2014 by the United States Patent and Trademark Office.

Quintessence Biosciences
Quintessence Biosciences
United States Patent and Trademark Office
United States Patent and Trademark Office
8697062
April 15, 2014
‌
US Patent 8628768 Therapeutic ribonucleases

Patent 8628768 was granted and assigned to Quintessence Biosciences on January, 2014 by the United States Patent and Trademark Office.

Quintessence Biosciences
Quintessence Biosciences
United States Patent and Trademark Office
United States Patent and Trademark Office
8628768
January 14, 2014
‌
US Patent 8216567 Therapeutic ribonucleases

Patent 8216567 was granted and assigned to Quintessence Biosciences on July, 2012 by the United States Patent and Trademark Office.

Quintessence Biosciences
Quintessence Biosciences
United States Patent and Trademark Office
United States Patent and Trademark Office
8216567
July 10, 2012
‌
US Patent 9579365 Therapeutic ribonucleases

Patent 9579365 was granted and assigned to Quintessence Biosciences on February, 2017 by the United States Patent and Trademark Office.

Quintessence Biosciences
Quintessence Biosciences
Quintessence Biosciences
Quintessence Biosciences
United States Patent and Trademark Office
United States Patent and Trademark Office
9579365
February 28, 2017
‌
US Patent 9393319 Non-natural ribonuclease conjugates as cytotoxic agents

Patent 9393319 was granted and assigned to Quintessence Biosciences on July, 2016 by the United States Patent and Trademark Office.

Quintessence Biosciences
Quintessence Biosciences
Quintessence Biosciences
Quintessence Biosciences
United States Patent and Trademark Office
United States Patent and Trademark Office
9393319
July 19, 2016
‌
US Patent 9192656 Methods and compositions for the treatment of cancer

Patent 9192656 was granted and assigned to Quintessence Biosciences on November, 2015 by the United States Patent and Trademark Office.

Quintessence Biosciences
Quintessence Biosciences
United States Patent and Trademark Office
United States Patent and Trademark Office
9192656
November 24, 2015
‌
US Patent 8840882 Modified ribonucleases

Quintessence Biosciences
Quintessence Biosciences
United States Patent and Trademark Office
United States Patent and Trademark Office
8840882
September 23, 2014
‌
US Patent 8298801 Methods and compositions for the treatment of cancer

Patent 8298801 was granted and assigned to Quintessence Biosciences on October, 2012 by the United States Patent and Trademark Office.

Quintessence Biosciences
Quintessence Biosciences
United States Patent and Trademark Office
United States Patent and Trademark Office
8298801
October 30, 2012
‌
US Patent 8470315 Non-natural ribonuclease conjugates as cytotoxic agents

Patent 8470315 was granted and assigned to Quintessence Biosciences on June, 2013 by the United States Patent and Trademark Office.

Quintessence Biosciences
Quintessence Biosciences
United States Patent and Trademark Office
United States Patent and Trademark Office
8470315
June 25, 2013
12 results
0 selected
12 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us